Distinct roles of the DRY motif in rat melanin-concentrating hormone receptor 1 in signaling control

Peptides

Volumn 30, Issue 5, 2009, Pages 974-981

  Aizaki, Yoshimi ^b   Maruyama, Kei ^b   Nakano Tetsuka, Mitsue ^c   Saito, Yumiko ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Calcium influx; Constitutive activation; DRY motif; G protein coupled receptor; Melanin concentrating hormone; Site directed mutagenesis

Indexed keywords

CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE; HORMONE RECEPTOR; MELANIN;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CALCIUM MOBILIZATION; CONTROLLED STUDY; HORMONE ACTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

AMINO ACID MOTIFS; CELL LINE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; RECEPTORS, SOMATOSTATIN; SIGNAL TRANSDUCTION;

RATTUS;

EID: 67349179667     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.01.017     Document Type: Article

References (37)

1. Acharya S., and Karnik S.S. Modulation of GDP release from transducin by the conserved Glu134-Arg135 sequence in rhodopsin. J Biol Chem 271 (1996) 25406-25411
2. 2 receptor. Mol Pharmacol 57 (2000) 890-898
3. Arora K.K., Zhengyi Z., Cheng Z., and Catt K.J. Mutations of the conserved DRS motif in the second intracellular loop of the gonadotropin-releasing hormone receptor affect expression, activation, and internalization. Mol Endocrinol 11 (1997) 1203-1212
4. Borowsky B., Durkin M.M., Ogozalek K., Marzabadi M.R., DeLeon J., Lagu B., et al. Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat Med 8 (2002) 825-830
5. Chaki S., Funakoshi T., Hirota-Okuno S., Nishiguchi M., Shimazaki T., Iijima M., et al. Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists. J Pharmacol Exp Ther 313 (2005) 831-839
6. Chambers J., Ames R.S., Bergsma D., Muir A., Fitgerals L.R., Hervieu G., et al. Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature 400 (1999) 261-265
7. Chung D.A., Wade S.M., Fowler C.B., Woods D.D., Abada P.B., Mosberg H.I., et al. Mutagenesis and peptide analysis of the DRY motif in the alpha2A adrenergic receptor: evidence for alternate mechanisms in G protein-coupled receptors. Biochem Biophys Res Commun 293 (2002) 1233-1241
8. Fan J., Perry S.J., Gao Y., Schwarz D.A., and Maki R.A. A point mutation in the human melanin concentrating hormone receptor 1 reveals an important domain for cellular trafficking. Mol Endocrinol 19 (2005) 2579-2590
9. Fanelli F., Barbier P., Zanchentta D., De Benedetti P.G., and Chini B. Activation mechanism of human oxytocin receptor: a combined study of experimental and computer-simulated mutagenesis. Mol Pharmacol 56 (1999) 214-225
10. Feng W., and Song Z.H. Effects of D3.49A, R3. 50A and A6. 34E mutations on ligand binding of the activation of the cannabinoid-2(CB2) receptor. Biochem Pharmacol 65 (2003) 1077-1085
11. Franke R.R., Sakmar T.P., Graham R.M., and Khorana H.G. Structure and function in rhodopsin. Studies of the interaction between the rhodopsin cytoplasmic domain and transducin. J Biol Chem 267 (1992) 14767-14774
12. Fredriksson R., Lagerstrom M.C., Lundin L.-G., and Schioth H.B. The G-protein-coupled receptors in the human genome form five families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63 (2003) 1256-1272
13. Fredriksson R., and Schioth H.B. The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol Pharmacol 67 (2005) 1414-1425
14. Hawes B.E., Kil E., Green B., O'Neill K., Fried S., and Graziano M.P. The melanin-concentrating hormone couples to multiple G proteins to activate diverse intracellular signaling pathways. Endocrinology 141 (2000) 4524-4532
15. Hawtin S.R. Charged residues of the conserved DRY triplet of the vasopressin V1a receptor provide molecular determinants for cell surface delivery and internalization. Mol Pharamacol 68 (2005) 1172-1182
16. Hill J., Duckworth M., Murdock P., Rennie G., Sabido-David C., Ames R.S., et al. Molecular cloning and functional characterization of MCH2, a novel human MCH receptor. J Biol Chem 276 (2001) 20125-20129
17. Kawauchi H., Kawazoe I., Tsubokawa M., Kishida M., and Baker B.L. Characterization of melanin-concentrating hormone in chum salmon pituitaries. Nature 305 (1983) 321-323
18. Li J., Huang P., Chen C., de Riel J.K., Weinstein H., and Liu-Chen L.Y. Constitutive activation of the mu opioid receptor by mutation of D3.49(164), but not D3.32(147): D3. 49(164) is critical for stabilization of the inactive form of the receptor and for its expression. Biochemistry 40 (2001) 12039-12050
19. Lu Z.L., Curtis C.A., Jones P.G., Pavia J., and Hulme E.C. The role of the aspartate-arginine-tyrosine triad in the m1 muscarinic receptor: mutations of aspartate 122 and tyrosine 124 decrease receptor expression but do not abolish signaling. Mol Pharmacol 51 (1997) 234-241
20. MacDonald D., Murgolo N., Zhang R., Durkin J.P., Yao X., Strader C.D., et al. Molecular characterization of the melanin-concentrating hormone/receptor complex: identification of critical residues involved in binding and activation. Mol Pharmacol 58 (2000) 217-225
21. Marsh D.J., Weingarth D.T., Novi D.E., Chen H.Y., Trumbauer M.E., Chen A.S., et al. Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci USA 99 (2002) 3240-3245
22. Palczewski K., Takashi Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
23. 2.50 and ERY motif reveals signaling bias of the urotensin II receptor. Mol Pharmacol 74 (2008) 552-561
24. Rasmussen S.G., Jensen A.D., Liapakis G., Ghanouni P., Javitch J.A., and Gether U. Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6. Mol Pharmacol 56 (1999) 175-184
25. Rovati E.G., Capra V., and Neubig R.R. The highly conserved DRY motif of class A G-protein-coupled receptors: beyond the ground state. Mol Pharmacol 71 (2007) 959-964
26. Saito Y., Nothacker H.P., Wang Z., Lin S.H.S., Leslie F., and Civelli O. Molecular characterization of the melanin-concentrating-hormone receptor. Nature 400 (1999) 265-269
27. Saito Y., Tetsuka M., Kawamura Y., Li Y., and Maruyama K. Role of asparagine-linked oligosaccharides in the function of the melanin-concentrating hormone (MCH) receptor 1. FEBS Lett 533 (2003) 229-234
28. Saito Y., Tetsuka M., Li Y., Kurose H., and Maruyama K. Properties of rat melanin-concentrating hormone receptor 1 internalization. Peptide 25 (2004) 1597-1604
29. Saito Y., Tetsuka M., Saito S., Imai K., Yoshikawa A., Doi H., et al. Arginine residue 155 in the second intracellular loop plays a critical role in rat melanin-concentrating hormone receptor 1. Endocrinology 146 (2005) 3452-3462
30. Scheer A., Fanelli F., Costa T., De Benedetti P.G., and Cotecchia S. The activation process of the α1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc Natl Acad Sci USA 94 (1997) 808-813
31. Scheer A., Costa T., Fanelli F., De Benedetti P.G., Mhaouty-Kodja S., Abuin L., et al. Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: effects on receptor isomerization and activation. Mol Pharmacol 57 (2000) 219-231
32. Scheerer P., Park J.H., Hildebrand P.W., Kim Y.J., Krau N., Choe H.-W., et al. Crystal structure of opsin in its G-protein-interacting conformation. Nature 455 (2008) 497-502
33. Segal-Lieberman G., Bradley R.L., Kokkotou E., Carlson M., Trombly D.J., Wang X., et al. Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype. Proc Natl Acad Sci USA 100 (2003) 10085-10090
34. Shimada M., Tritos N.A., Lowell B.B., Flier J.S., and Maratos-Flier E. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396 (1998) 670-674
35. Takekawa S., Asami A., Ishihara Y., Terauchi J., Kato K., Shimomura Y., et al. T-226296: A novel, orally active and selective melanin-concentrating hormone receptor antagonist. Eur J Pharmacol 438 (2002) 129-135
36. Tan C.P., Sano H., Iwaasa H., Pan J., Sailer A.W., Hreniuk D.L., et al. Melanin-concentrating hormone receptor subtypes 1 and 2: Species-specific gene expression. Genomics 79 (2002) 785-792
37. Tetsuka M., Saito Y., Imai K., Doi H., and Maruyama K. The basic residues in the membrane-proximal C-terminal tail of the rat melanin-concentrating hormone receptor 1 are required for receptor function. Endocrinology 145 (2004) 3712-3723